TrialX
Advanced Filters
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
noise

Found 3,739 clinical trials

D Dr Clemency, MD

A Study of the Safety and Efficacy of Ciclesonide in the Treatment of Non-hospitalized COVID-19 Patients

The purpose of this study is to assess the safety and efficacy of Alvesco (ciclesonide) Inhalation Aerosol in non hospitalized patients with symptomatic COVID-19 infection in a multicenter, randomized, double-blind, placebo controlled study

12 years and older All Phase 3
M Michelle Harkins, MD

Treatment With Investigational Convalescent Plasma and Measure Antibody Levels in Patients Hospitalized With COVID-19

This is an open label pilot study designed to provide access to treatment with investigational convalescent plasma and assess the relationship between NAb titers in the investigational convalescent plasma compared to changes in NAb levels in the recipient in hospitalized patients with COVID-19.

18 years and older All Phase 2
C Clinical Trials Registration Coordinator

Treatment With CSL312 in Adults With Coronavirus Disease 2019 (COVID 19)

This is a prospective, phase 2, multicenter, randomized, double blind, placebo controlled, parallel group study to assess the safety and efficacy of CSL312 administered intravenously, in combination with standard of care (SOC) treatment, in patients with Coronavirus disease 2019 (COVID 19)

18 years and older All Phase 2
A AstraZeneca Clinical Study Information Center

Mobile Devices to Detect Early Pneumonitis in Stage III NSCLC Patients on Durvalumab.

A study of whether mobile devices can improve the detection of pulmonary AEs (including pneumonitis) in stage III NSCLC patients post-CRT, while on durvalumab.

18 years and older All Phase 4
T Tom Wilkinson

Trial of Inhaled Anti-viral (SNG001) for SARS-CoV-2 (COVID-19) Infection

SNG001 is an inhaled drug that contains a antiviral protein called interferon beta (IFN-). IFN- in produced in the lungs during viral lung infections. It has been shown that older people and people with some chronic diseases have an IFN- deficiency. Many viruses inhibit IFN- as part of their strategy …

18 years and older All Phase 2
H Hsien-Yuan Lane, M.D., Ph.D

Multidisciplinary Study of Novel NMDA Modulation for Neurodegenerative Disorder

Alzheimer's disease (AD) and Parkinson's disease (PD) are currently the leading neurodegenerative disorders. Considering the fact that aged population is rapidly growing, it has become a critical issue to find more effective medications for these two disorders. The aim of this project is to examine the effectiveness and safety of …

50-90 years All Phase 2
E Email contact via H. Lundbeck A/S

Safety and Tolerability of Lu AG06479 in Healthy Young Men

The purpose of this study is to investigate the safety and tolerability of Lu AG06479 and what the body does to Lu AG06479 after swallowing single doses of the drug

18-45 years Male Phase 1
J Jamilia R Sly, PhD

Increasing African Immigrant Women's Participation in Breast Cancer Screening

New York City (NYC) is home to a large and diverse immigrant population. Many of these groups face significant barriers to preventive health care, including lack of insurance, poor health care access and language difficulties. Most African immigrant women are likely to live below the poverty line and have low …

18-74 years All Phase N/A
S Seung-hoe Song, MBE

A Clinical Trial to Evaluate the Effect of Nilotinib on the PK/PD of Meformin

The aim of the study is to evaluate the effect of nilotinib on the pharmacokinetics and pharmacodynamics of metformin in healthy male adults

19-50 years Male Phase 1
J Jean-Marie Houle, PhD

Study of LAU-7b for the Treatment of COVID-19 Disease in Adults

A randomized, double-blind, placebo-controlled Phase 2 Study of LAU-7b against confirmed COVID-19 Disease in hospitalized patients at a higher risk of complications.

45 years and older All Phase 2

Simplify language using AI